Small Biotechs Are Valuable for Big Pharma… and Your Portfolio

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

Historically, pharmaceutical companies have worked their way through their down cycles by painstakingly developing new drugs, in the hopes that some of them become future blockbusters. But a powerful a new trend is emerging...

The post Small Biotechs Are Valuable for Big Pharma… and Your Portfolio appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”